Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward P Havranek

TitlePrincipal Investigator
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Research 
    Collapse research activities and funding
    P20CA210677     (CAMPBELL, THOMAS B.)Sep 20, 2017 - Aug 31, 2020
    NIH
    African Center for the Advancement of Research Excellence (AfriCARE)
    Role: Co-Principal Investigator

    K12HL137862     (GLASGOW, RUSSELL E)Sep 5, 2017 - Jun 30, 2022
    NIH
    IMPlementation to Achieve Clinical Transformation (IMPACT): The Colorado Training Program
    Role: Co-Principal Investigator

    R24HS022143     (HAVRANEK, EDWARD PAUL)Apr 1, 2013 - Jan 31, 2019
    NIH
    Developing Infrastructure for Patient-Centered Outcomes Research at Denver Health
    Role: Principal Investigator

    R21HL089623     (HAVRANEK, EDWARD)Sep 1, 2009 - May 31, 2012
    NIH
    An Intervention to Reduce the Effect of Racial/Ethnic Bias on Hypertension Care
    Role: Principal Investigator

    U01HL079160     (HAVRANEK, EDWARD)Sep 30, 2004 - Aug 31, 2010
    NIH
    Latinos Using Cardio Health Actions to Reduce Risk
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mansoori JN, Clark BJ, Havranek EP, Douglas IS. The Impact of Choice Architecture on Sepsis Fluid Resuscitation Decisions: An Exploratory Survey-Based Study. MDM Policy Pract. 2022 Jan-Jun; 7(1):23814683221099454. PMID: 35592271.
      View in: PubMed
    2. Henderson KH, Helmkamp LJ, Steiner JF, Havranek EP, Vupputuri SX, Hanratty R, Blair IV, Maertens JA, Dickinson M, Daugherty SL. Relationship Between Social Vulnerability Indicators and Trial Participant Attrition: Findings From the HYVALUE Trial. Circ Cardiovasc Qual Outcomes. 2022 May; 15(5):e007709. PMID: 35418247.
      View in: PubMed
    3. Daugherty SL, Helmkamp L, Vupputuri S, Hanratty R, Steiner JF, Blair IV, Dickinson LM, Maertens JA, Havranek EP. Effect of Values Affirmation on Reducing Racial Differences in Adherence to Hypertension Medication: The HYVALUE Randomized Clinical Trial. JAMA Netw Open. 2021 12 01; 4(12):e2139533. PMID: 34913976.
      View in: PubMed
    4. Maw AM, Ho PM, Morris MA, Glasgow RE, Huebschmann AG, Barnard JG, Metter R, Tierney DM, Mathews BK, Havranek EP, Kissler M, Fleshner M, Burian BK, Platz E, Soni NJ. Hospitalist Perceptions of Barriers to Lung Ultrasound Adoption in Diverse Hospital Environments. Diagnostics (Basel). 2021 Aug 11; 11(8). PMID: 34441385.
      View in: PubMed
    5. Havranek EP. Does Health Inequity Begin at Home? JAMA Cardiol. 2021 08 01; 6(8):889-890. PMID: 34009237.
      View in: PubMed
    6. Trent SA, George N, Havranek EP, Ginde AA, Haukoos JS. Established evidence-based treatment guidelines help mitigate disparities in quality of emergency care. Acad Emerg Med. 2021 09; 28(9):1051-1060. PMID: 33599040.
      View in: PubMed
    7. Perman SM, Beaty BL, Daugherty SL, Havranek EP, Haukoos JS, Juarez-Colunga E, Bradley SM, Fendler TJ, Chan PS. Do Sex Differences Exist in the Establishment of "Do Not Attempt Resuscitation" Orders and Survival in Patients Successfully Resuscitated From In-Hospital Cardiac Arrest? J Am Heart Assoc. 2020 02 18; 9(4):e014200. PMID: 32063126.
      View in: PubMed
    8. Rinehart DJ, Leslie SE, Kuka K, Doyle R, Stowell M, Thomas-Gale T, Shlay JC, Havranek EP, Albright K. Adolescent Female Perspectives in an Urban Safety Net: Developing an Intervention Focusing on Sexual Health and Text-Messaging. J Health Care Poor Underserved. 2020; 31(3):1379-1398. PMID: 33416701.
      View in: PubMed
    9. Mould-Millman NK, Dixon J, Lamp A, de Vries S, Beaty B, Finck L, Colborn K, Moodley K, Skenadore A, Glasgow RE, Havranek EP, Bebarta VS, Ginde AA. A single-site pilot implementation of a novel trauma training program for prehospital providers in a resource-limited setting. Pilot Feasibility Stud. 2019; 5:143. PMID: 31844551.
      View in: PubMed
    10. Havranek EP. The Influence of Social and Economic Factors on Heart Disease. JAMA Cardiol. 2019 12 01; 4(12):1212-1213. PMID: 31596424.
      View in: PubMed
    11. Vogel JA, Rising KL, Jones J, Bowden ML, Ginde AA, Havranek EP. Reasons Patients Choose the Emergency Department over Primary Care: a Qualitative Metasynthesis. J Gen Intern Med. 2019 11; 34(11):2610-2619. PMID: 31428988.
      View in: PubMed
    12. Perman SM, Siry BJ, Ginde AA, Grossestreuer AV, Abella BS, Daugherty SL, Havranek EP. Sex Differences in "Do Not Attempt Resuscitation" Orders After Out-of-Hospital Cardiac Arrest and the Relationship to Critical Hospital Interventions. Clin Ther. 2019 06; 41(6):1029-1037. PMID: 31047712.
      View in: PubMed
    13. Daugherty SL, Vupputuri S, Hanratty R, Steiner JF, Maertens JA, Blair IV, Dickinson LM, Helmkamp L, Havranek EP. Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Protocol for the Multicenter Randomized Hypertension and Values (HYVALUE) Trial. JMIR Res Protoc. 2019 Mar 25; 8(3):e12498. PMID: 30907744.
      View in: PubMed
    14. Perman SM, Shelton SK, Knoepke C, Rappaport K, Matlock DD, Adelgais K, Havranek EP, Daugherty SL. Public Perceptions on Why Women Receive Less Bystander Cardiopulmonary Resuscitation Than Men in Out-of-Hospital Cardiac Arrest. Circulation. 2019 02 19; 139(8):1060-1068. PMID: 30779655.
      View in: PubMed
    15. Trent SA, Jarou ZJ, Havranek EP, Ginde AA, Haukoos JS. Variation in Emergency Department Adherence to Treatment Guidelines for Inpatient Pneumonia and Sepsis: A Retrospective Cohort Study. Acad Emerg Med. 2019 08; 26(8):908-920. PMID: 30343515.
      View in: PubMed
    16. Trent SA, Morse EA, Ginde AA, Havranek EP, Haukoos JS. Barriers to Prompt Presentation to Emergency Departments in Colorado after Onset of Stroke Symptoms. West J Emerg Med. 2019 Mar; 20(2):237-243. PMID: 30881542.
      View in: PubMed
    17. Ritchie ND, Carroll JK, Holtrop JS, Havranek EP. Effects of physical activity goal attainment on engagement and outcomes in the National Diabetes Prevention Program. Transl Behav Med. 2018 11 21; 8(6):932-937. PMID: 29669050.
      View in: PubMed
    18. Trent SA, Havranek EP, Ginde AA, Haukoos JS. Effect of Audit and Feedback on Physician Adherence to Clinical Practice Guidelines for Pneumonia and Sepsis. Am J Med Qual. 2019 May/Jun; 34(3):217-225. PMID: 30205697.
      View in: PubMed
    19. Magnani JW, Mujahid MS, Aronow HD, Cené CW, Dickson VV, Havranek E, Morgenstern LB, Paasche-Orlow MK, Pollak A, Willey JZ. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary and Secondary Prevention: A Scientific Statement From the American Heart Association. Circulation. 2018 07 10; 138(2):e48-e74. PMID: 29866648.
      View in: PubMed
    20. Doyle R, Albright K, Hurley LP, Chávez C, Stowell M, Dircksen S, Havranek EP, Anderson M. Patient Perspectives on a Text Messaging Program to Support Asthma Management: A Qualitative Study. Health Promot Pract. 2019 07; 20(4):585-592. PMID: 29732922.
      View in: PubMed
    21. Bekelman DB, Allen LA, McBryde CF, Hattler B, Fairclough DL, Havranek EP, Turvey C, Meek PM. Effect of a Collaborative Care Intervention vs Usual Care on Health Status of Patients With Chronic Heart Failure: The CASA Randomized Clinical Trial. JAMA Intern Med. 2018 04 01; 178(4):511-519. PMID: 29482218.
      View in: PubMed
    22. Hakim JG, Chidzonga MM, Borok MZ, Nathoo KJ, Matenga J, Havranek E, Cowan F, Abas M, Aagaard E, Connors S, Nkomani S, Ndhlovu CE, Matsika A, Barry M, Campbell TB. Medical Education Partnership Initiative (MEPI) in Zimbabwe: Outcomes and Challenges. Glob Health Sci Pract. 2018 03 21; 6(1):82-92. PMID: 29602867.
      View in: PubMed
    23. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29334514.
      View in: PubMed
    24. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 29402689.
      View in: PubMed
    25. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28830862.
      View in: PubMed
    26. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 27926904.
      View in: PubMed
    27. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28336351.
      View in: PubMed
    28. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 28320212.
      View in: PubMed
    29. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 20031876.
      View in: PubMed
    30. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 24549521.
      View in: PubMed
    31. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 26244013.
      View in: PubMed
    32. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18698603.
      View in: PubMed
    33. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 19288160.
      View in: PubMed
    34. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 16520265.
      View in: PubMed
    35. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 12751130.
      View in: PubMed
    36. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23319505.
      View in: PubMed
    37. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 14691421.
      View in: PubMed
    38. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 13680543.
      View in: PubMed
    39. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 12511120.
      View in: PubMed
    40. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 11790919.
      View in: PubMed
    41. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 12796754.
      View in: PubMed
    42. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15222667.
      View in: PubMed
    43. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 14656840.
      View in: PubMed
    44. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15013127.
      View in: PubMed
    45. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 20354220.
      View in: PubMed
    46. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 22392529.
      View in: PubMed
    47. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 16500581.
      View in: PubMed
    48. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17306718.
      View in: PubMed
    49. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 16162914.
      View in: PubMed
    50. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15983243.
      View in: PubMed
    51. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23153155.
      View in: PubMed
    52. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 23375928.
      View in: PubMed
    53. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 19840562.
      View in: PubMed
    54. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18342879.
      View in: PubMed
    55. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17923356.
      View in: PubMed
    56. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18469416.
      View in: PubMed
    57. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 19007690.
      View in: PubMed
    58. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15122842.
      View in: PubMed
    59. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17296854.
      View in: PubMed
    60. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30270096.
      View in: PubMed
    61. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 30702365.
      View in: PubMed
    62. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 31449454.
      View in: PubMed
    63. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 31560971.
      View in: PubMed
    64. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 31992351.
      View in: PubMed
    65. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 33400608.
      View in: PubMed
    66. Beck A, Davidson AJ, Xu S, Josh Durfee M, Oronce CIA, Steiner JF, Havranek E. A Multilevel Analysis of Individual, Health System, and Neighborhood Factors Associated with Depression within a Large Metropolitan Area. J Urban Health. 2017 Dec; 94(6):780-790. PMID: 28842803.
      View in: PubMed
    67. Daugherty SL, Blair IV, Havranek EP, Furniss A, Dickinson LM, Karimkhani E, Main DS, Masoudi FA. Implicit Gender Bias and the Use of Cardiovascular Tests Among Cardiologists. J Am Heart Assoc. 2017 Nov 29; 6(12). PMID: 29187391.
      View in: PubMed
    68. Bekelman DB, Allen LA, Peterson J, Hattler B, Havranek EP, Fairclough DL, McBryde CF, Meek PM. Rationale and study design of a patient-centered intervention to improve health status in chronic heart failure: The Collaborative Care to Alleviate Symptoms and Adjust to Illness (CASA) randomized trial. Contemp Clin Trials. 2016 11; 51:1-7. PMID: 27634669.
      View in: PubMed
    69. Perman SM, Havranek EP. Exploring Providers' Perspectives on Early Decisions to Withdraw Life-Sustaining Therapy after Cardiac Arrest. One Side of the Story. Ann Am Thorac Soc. 2016 07; 13(7):1008-9. PMID: 27388400.
      View in: PubMed
    70. Pflederer MC, Long CS, Beaty B, Havranek EP, Mehler PS, Keniston A, Krantz MJ. Longitudinal Changes in Vascular Risk Markers and Mortality Rates among a Latino Population with Hypertension. Tex Heart Inst J. 2016 Apr; 43(2):131-6. PMID: 27127427.
      View in: PubMed
    71. Fischer HH, Fischer IP, Pereira RI, Furniss AL, Rozwadowski JM, Moore SL, Durfee MJ, Raghunath SG, Tsai AG, Havranek EP. Text Message Support for Weight Loss in Patients With Prediabetes: A Randomized Clinical Trial. Diabetes Care. 2016 Aug; 39(8):1364-70. PMID: 26861922.
      View in: PubMed
    72. Pereira RI, Low Wang CC, Wolfe P, Havranek EP, Long CS, Bessesen DH. Associations of Adiponectin with Adiposity, Insulin Sensitivity, and Diet in Young, Healthy, Mexican Americans and Non-Latino White Adults. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010054. PMID: 26703682.
      View in: PubMed
    73. Moore SL, Fischer I, Havranek EP. Translating Health Services Research into Practice in the Safety Net. Health Serv Res. 2016 Feb; 51(1):16-31. PMID: 26646189.
      View in: PubMed
    74. Krantz MJ, Havranek EP, Pereira RI, Beaty B, Mehler PS, Long CS. Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study. J Negat Results Biomed. 2015 Dec 02; 14:21. PMID: 26631058.
      View in: PubMed
    75. Martin SS, Faridi KF, Joshi PH, Blaha MJ, Kulkarni KR, Khokhar AA, Maddox TM, Havranek EP, Toth PP, Tang F, Spertus JA, Jones SR. Remnant Lipoprotein Cholesterol and Mortality After Acute Myocardial Infarction: Further Evidence for a Hypercholesterolemia Paradox From the TRIUMPH Registry. Clin Cardiol. 2015 Nov; 38(11):660-7. PMID: 26459191.
      View in: PubMed
    76. Havranek EP, Mujahid MS, Barr DA, Blair IV, Cohen MS, Cruz-Flores S, Davey-Smith G, Dennison-Himmelfarb CR, Lauer MS, Lockwood DW, Rosal M, Yancy CW. Social Determinants of Risk and Outcomes for Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2015 Sep 01; 132(9):873-98. PMID: 26240271.
      View in: PubMed
    77. Havranek EP. Capturing complexity: socioeconomic disadvantage and heart failure outcomes. Circ Heart Fail. 2015 May; 8(3):413-4. PMID: 25991801.
      View in: PubMed
    78. Havranek EP, Hanratty R, Tate C, Dickinson LM, Steiner JF, Cohen G, Blair IA. The effect of values affirmation on race-discordant patient-provider communication. Arch Intern Med. 2012 Nov 26; 172(21):1662-7. PMID: 23128568.
      View in: PubMed
    79. Schroeder EB, Hanratty R, Beaty BL, Bayliss EA, Havranek EP, Steiner JF. Simultaneous control of diabetes mellitus, hypertension, and hyperlipidemia in 2 health systems. Circ Cardiovasc Qual Outcomes. 2012 Sep 01; 5(5):645-53. PMID: 22851534.
      View in: PubMed
    80. Havranek EP. ACP Journal Club. Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years. Ann Intern Med. 2012 Mar 20; 156(6):JC3-5. PMID: 22431691.
      View in: PubMed
    81. Peterson PN, Campagna EJ, Maravi M, Allen LA, Bull S, Steiner JF, Havranek EP, Dickinson LM, Masoudi FA. Acculturation and outcomes among patients with heart failure. Circ Heart Fail. 2012 Mar 01; 5(2):160-6. PMID: 22247483.
      View in: PubMed
    82. Havranek EP. ACP Journal Club. Review: A Mediterranean diet reduces cardiovascular risk factors in overweight patients compared with a low-fat diet. Ann Intern Med. 2011 Dec 20; 155(12):JC6-3. PMID: 22184704.
      View in: PubMed
    83. Hanratty R, Chonchol M, Havranek EP, Powers JD, Dickinson LM, Ho PM, Magid DJ, Steiner JF. Relationship between blood pressure and incident chronic kidney disease in hypertensive patients. Clin J Am Soc Nephrol. 2011 Nov; 6(11):2605-11. PMID: 21921154.
      View in: PubMed
    84. Hakim JG, Matenga JA, Havranek E, Koa D. Health Workforce Development with a Focus on CVD in Zimbabwe CHRIS Program, a Medical Education Partnership Initiative. Glob Heart. 2011 Dec; 6(4):219-20. PMID: 25691049.
      View in: PubMed
    85. Pereira RI, Wang CC, Hosokawa P, Dickinson LM, Chonchol M, Krantz MJ, Steiner JF, Bessesen DH, Havranek EP, Long CS. Circulating adiponectin levels are lower in Latino versus non-Latino white patients at risk for cardiovascular disease, independent of adiposity measures. BMC Endocr Disord. 2011 Jul 07; 11:13. PMID: 21736747.
      View in: PubMed
    86. Fitzgerald AA, Powers JD, Ho PM, Maddox TM, Peterson PN, Allen LA, Masoudi FA, Magid DJ, Havranek EP. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011 Aug; 17(8):664-9. PMID: 21807328.
      View in: PubMed
    87. Krantz MJ, Long CS, Hosokawa P, Karimkahani E, Dickinson M, Estacio RO, Masoudi FA, Havranek EP. Pulse wave velocity and carotid atherosclerosis in white and Latino patients with hypertension. BMC Cardiovasc Disord. 2011 Apr 11; 11:15. PMID: 21481252.
      View in: PubMed
    88. Padilla R, Steiner JF, Havranek EP, Beaty B, Davidson AJ, Bull S. A comparison of different measures of acculturation with cardiovascular risk factors in Latinos with hypertension. J Immigr Minor Health. 2011 Apr; 13(2):284-92. PMID: 21221808.
      View in: PubMed
    89. Magid DJ, Ho PM, Olson KL, Brand DW, Welch LK, Snow KE, Lambert-Kerzner AC, Plomondon ME, Havranek EP. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011 Apr; 17(4):e96-103. PMID: 21774100.
      View in: PubMed
    90. Blair IV, Steiner JF, Havranek EP. Unconscious (implicit) bias and health disparities: where do we go from here? Perm J. 2011; 15(2):71-8. PMID: 21841929.
      View in: PubMed
    91. Welch LK, Olson KL, Snow KE, Pointer L, Lambert-Kerzner A, Havranek EP, Magid DJ, Ho PM. Systolic blood pressure control after participation in a hypertension intervention study. Am J Manag Care. 2011; 17(7):473-8. PMID: 21819167.
      View in: PubMed
    92. Lambert-Kerzner A, Havranek EP, Plomondon ME, Albright K, Moore A, Gryniewicz K, Magid D, Ho PM. Patients' perspectives of a multifaceted intervention with a focus on technology: a qualitative analysis. Circ Cardiovasc Qual Outcomes. 2010 Nov; 3(6):668-74. PMID: 20923992.
      View in: PubMed
    93. Hurley LP, Dickinson LM, Estacio RO, Steiner JF, Havranek EP. Prediction of cardiovascular death in racial/ethnic minorities using Framingham risk factors. Circ Cardiovasc Qual Outcomes. 2010 Mar; 3(2):181-7. PMID: 20124526.
      View in: PubMed
    94. Havranek EP, Peterson PN. Are implanted defibrillators effective therapy in the elderly?: Asked, not answered. Circ Heart Fail. 2010 Jan; 3(1):4-6. PMID: 20086220.
      View in: PubMed
    95. Blair IV, Judd CM, Havranek EP, Steiner JF. Using Community Data to Test the Discriminate Validity of Ethnic/Racial Group IATs. Z Psychol. 2010 Jan 01; 218(1). PMID: 24404433.
      View in: PubMed
    96. Hanratty R, Chonchol M, Miriam Dickinson L, Beaty BL, Estacio RO, Mackenzie TD, Hurley LP, Linas SL, Steiner JF, Havranek EP. Incident chronic kidney disease and the rate of kidney function decline in individuals with hypertension. Nephrol Dial Transplant. 2010 Mar; 25(3):801-7. PMID: 19889870.
      View in: PubMed
    97. Riegel B, Moser DK, Anker SD, Appel LJ, Dunbar SB, Grady KL, Gurvitz MZ, Havranek EP, Lee CS, Lindenfeld J, Peterson PN, Pressler SJ, Schocken DD, Whellan DJ. State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association. Circulation. 2009 Sep 22; 120(12):1141-63. PMID: 19720935.
      View in: PubMed
    98. Krumholz HM, Wang Y, Chen J, Drye EE, Spertus JA, Ross JS, Curtis JP, Nallamothu BK, Lichtman JH, Havranek EP, Masoudi FA, Radford MJ, Han LF, Rapp MT, Straube BM, Normand SL. Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA. 2009 Aug 19; 302(7):767-73. PMID: 19690309.
      View in: PubMed
    99. Havranek EP. Atrial fibrillation through the patient's eyes. Circ Arrhythm Electrophysiol. 2009 Jun; 2(3):213-4. PMID: 19808469.
      View in: PubMed
    100. Havranek EP. Reply to: Should physicians aggressively treat pre-hypertension? Am J Med. 2009 May 01; 122(5):e21. PMID: 20717475.
      View in: PubMed
    101. Kosiborod M, Inzucchi SE, Spertus JA, Wang Y, Masoudi FA, Havranek EP, Krumholz HM. Elevated admission glucose and mortality in elderly patients hospitalized with heart failure. Circulation. 2009 Apr 14; 119(14):1899-907. PMID: 19332465.
      View in: PubMed
    102. Havranek EP, Froshaug DB, Emserman CD, Hanratty R, Krantz MJ, Masoudi FA, Dickinson LM, Steiner JF. Left ventricular hypertrophy and cardiovascular mortality by race and ethnicity. Am J Med. 2008 Oct; 121(10):870-5. PMID: 18823858.
      View in: PubMed
    103. Havranek EP. From black and white to shades of gray: race and renin-angiotensin system blockade. J Am Coll Cardiol. 2008 May 13; 51(19):1872-3. PMID: 18466802.
      View in: PubMed
    104. Krantz MJ, Havranek EP, Haynes DK, Smith I, Bucher-Bartelson B, Long CS. Inpatient initiation of beta-blockade plus nurse management in vulnerable heart failure patients: a randomized study. J Card Fail. 2008 May; 14(4):303-9. PMID: 18474343.
      View in: PubMed
    105. Padilla R, Bull S, Raghunath SG, Fernald D, Havranek EP, Steiner JF. Designing a cardiovascular disease prevention web site for Latinos: qualitative community feedback. Health Promot Pract. 2010 Jan; 11(1):140-7. PMID: 18385489.
      View in: PubMed
    106. Ho PM, Eng MH, Rumsfeld JS, Spertus JA, Peterson PN, Jones PG, Peterson ED, Alexander KP, Havranek EP, Krumholz HM, Masoudi FA. The influence of age on health status outcomes after acute myocardial infarction. Am Heart J. 2008 May; 155(5):855-61. PMID: 18440332.
      View in: PubMed
    107. Bekelman DB, Havranek EP. Palliative care for patients with acute decompensated heart failure: an underused service? Nat Clin Pract Cardiovasc Med. 2008 May; 5(5):250-1. PMID: 18283302.
      View in: PubMed
    108. Havranek EP. Elevated levels of nonfasting triglycerides were associated with increased risk for death, MI, and ischemic heart disease. ACP J Club. 2008 Jan-Feb; 148(1):23. PMID: 18171010.
      View in: PubMed
    109. Plomondon ME, Magid DJ, Masoudi FA, Jones PG, Barry LC, Havranek E, Peterson ED, Krumholz HM, Spertus JA, Rumsfeld JS. Association between angina and treatment satisfaction after myocardial infarction. J Gen Intern Med. 2008 Jan; 23(1):1-6. PMID: 17955303.
      View in: PubMed
    110. Havranek EP. Smoking cessation counseling and the quality of care for acute myocardial infarction. Am Heart J. 2007 Aug; 154(2):211-2. PMID: 17643568.
      View in: PubMed
    111. Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6. PMID: 17692744.
      View in: PubMed
    112. Havranek EP. Review: Framingham risk scores have variable accuracy in predicting CVD events in different patient populations. Evid Based Med. 2007 Jun; 12(3):87. PMID: 17537895.
      View in: PubMed
    113. Havranek EP. Review: Framingham risk scores have variable accuracy in predicting CVD events in different patient populations. ACP J Club. 2007 May-Jun; 146(3):80. PMID: 17474689.
      View in: PubMed
    114. Ko DT, Krumholz HM, Wang Y, Foody JM, Masoudi FA, Havranek EP, You JJ, Alter DA, Stukel TA, Newman AM, Tu JV. Regional differences in process of care and outcomes for older acute myocardial infarction patients in the United States and Ontario, Canada. Circulation. 2007 Jan 16; 115(2):196-203. PMID: 17190861.
      View in: PubMed
    115. Masoudi FA, Foody JM, Havranek EP, Wang Y, Radford MJ, Allman RM, Gold J, Wiblin RT, Krumholz HM. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: clinical characteristics, quality of care, and outcomes. Circulation. 2006 Dec 19; 114(25):2806-14. PMID: 17145994.
      View in: PubMed
    116. Conard MW, Haddock CK, Poston WS, Havranek E, McCullough P, Spertus J. Impact of obesity on the health status of heart failure patients. J Card Fail. 2006 Dec; 12(9):700-6. PMID: 17174231.
      View in: PubMed
    117. Rathore SS, Masoudi FA, Wang Y, Curtis JP, Foody JM, Havranek EP, Krumholz HM. Socioeconomic status, treatment, and outcomes among elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J. 2006 Aug; 152(2):371-8. PMID: 16875925.
      View in: PubMed
    118. Nallamothu BK, Payvar S, Wang Y, Kosiborod M, Masoudi FA, Havranek EP, Foody JM, Casscells SW, Krumholz HM. Admission body temperature and mortality in elderly patients hospitalized for heart failure. J Am Coll Cardiol. 2006 Jun 20; 47(12):2563-4. PMID: 16781389.
      View in: PubMed
    119. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med. 2006 May 22; 166(10):1134-42. PMID: 16717177.
      View in: PubMed
    120. Foody JM, Rathore SS, Galusha D, Masoudi FA, Havranek EP, Radford MJ, Krumholz HM. Hydroxymethylglutaryl-CoA reductase inhibitors in older persons with acute myocardial infarction: evidence for an age-statin interaction. J Am Geriatr Soc. 2006 Mar; 54(3):421-30. PMID: 16551308.
      View in: PubMed
    121. Foody JM, Shah R, Galusha D, Masoudi FA, Havranek EP, Krumholz HM. Statins and mortality among elderly patients hospitalized with heart failure. Circulation. 2006 Feb 28; 113(8):1086-92. PMID: 16490817.
      View in: PubMed
    122. Heidenreich PA, Spertus JA, Jones PG, Weintraub WS, Rumsfeld JS, Rathore SS, Peterson ED, Masoudi FA, Krumholz HM, Havranek EP, Conard MW, Williams RE. Health status identifies heart failure outpatients at risk for hospitalization or death. J Am Coll Cardiol. 2006 Feb 21; 47(4):752-6. PMID: 16487840.
      View in: PubMed
    123. Ko DT, Tu JV, Masoudi FA, Wang Y, Havranek EP, Rathore SS, Newman AM, Donovan LR, Lee DS, Foody JM, Krumholz HM. Quality of care and outcomes of older patients with heart failure hospitalized in the United States and Canada. Arch Intern Med. 2005 Nov 28; 165(21):2486-92. PMID: 16314545.
      View in: PubMed
    124. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, Havranek EP, Krumholz HM. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med. 2005 Oct 24; 165(19):2237-44. PMID: 16246989.
      View in: PubMed
    125. Masoudi FA, Baillie CA, Wang Y, Bradford WD, Steiner JF, Havranek EP, Foody JM, Krumholz HM. The complexity and cost of drug regimens of older patients hospitalized with heart failure in the United States, 1998-2001. Arch Intern Med. 2005 Oct 10; 165(18):2069-76. PMID: 16216996.
      View in: PubMed
    126. Foody JM, Rathore SS, Wang Y, Herrin J, Masoudi FA, Havranek EP, Krumholz HM. Physician specialty and mortality among elderly patients hospitalized with heart failure. Am J Med. 2005 Oct; 118(10):1120-5. PMID: 16194643.
      View in: PubMed
    127. Masoudi FA, Wolfe P, Havranek EP, Rathore SS, Foody JM, Krumholz HM. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005 Sep 20; 46(6):955-62. PMID: 16168275.
      View in: PubMed
    128. Luther SA, McCullough PA, Havranek EP, Rumsfeld JS, Jones PG, Heidenreich PA, Peterson ED, Rathore SS, Krumholz HM, Weintraub WS, Spertus JA, Masoudi FA. The relationship between B-type natriuretic peptide and health status in patients with heart failure. J Card Fail. 2005 Aug; 11(6):414-21. PMID: 16105631.
      View in: PubMed
    129. Inzucchi SE, Masoudi FA, Wang Y, Kosiborod M, Foody JM, Setaro JF, Havranek EP, Krumholz HM. Insulin-sensitizing antihyperglycemic drugs and mortality after acute myocardial infarction: insights from the National Heart Care Project. Diabetes Care. 2005 Jul; 28(7):1680-9. PMID: 15983320.
      View in: PubMed
    130. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP, Krumholz HM. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005 Jun 14; 111(23):3078-86. PMID: 15939812.
      View in: PubMed
    131. Krantz MJ, Zwang O, Rowan SB, Cleary B, Chu E, Reid MB, Cantrill SV, Havranek EP, Albert RK. A cooperative care model: cardiologists and hospitalists reduce length of stay in a chest pain observation unit. Crit Pathw Cardiol. 2005 Jun; 4(2):55-8. PMID: 18340186.
      View in: PubMed
    132. Havranek EP. Improving the outcomes of heart failure care: putting technology second. J Am Coll Cardiol. 2005 May 17; 45(10):1665-6. PMID: 15893184.
      View in: PubMed
    133. Strickberger SA, Conti J, Daoud EG, Havranek E, Mehra MR, Piña IL, Young J. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation. 2005 Apr 26; 111(16):2146-50. PMID: 15851622.
      View in: PubMed
    134. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation. 2005 Mar 15; 111(10):1270-7. PMID: 15769768.
      View in: PubMed
    135. Havranek EP, Steiner JF. Valuation of health states in the US versus the UK: two measures divided by a common language? Med Care. 2005 Mar; 43(3):201-2. PMID: 15725976.
      View in: PubMed
    136. Hauptman PJ, Havranek EP. Integrating palliative care into heart failure care. Arch Intern Med. 2005 Feb 28; 165(4):374-8. PMID: 15738365.
      View in: PubMed
    137. Masoudi FA, Inzucchi SE, Wang Y, Havranek EP, Foody JM, Krumholz HM. Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study. Circulation. 2005 Feb 08; 111(5):583-90. PMID: 15699279.
      View in: PubMed
    138. Rathore SS, Foody JM, Wang Y, Herrin J, Masoudi FA, Havranek EP, Ordin DL, Krumholz HM. Sex, quality of care, and outcomes of elderly patients hospitalized with heart failure: findings from the National Heart Failure Project. Am Heart J. 2005 Jan; 149(1):121-8. PMID: 15660043.
      View in: PubMed
    139. Havranek EP, Spertus JA, Masoudi FA, Jones PG, Rumsfeld JS. Predictors of the onset of depressive symptoms in patients with heart failure. J Am Coll Cardiol. 2004 Dec 21; 44(12):2333-8. PMID: 15607395.
      View in: PubMed
    140. Rathore SS, Masoudi FA, Havranek EP, Krumholz HM. Regional variations in racial differences in the treatment of elderly patients hospitalized with acute myocardial infarction. Am J Med. 2004 Dec 01; 117(11):811-22. PMID: 15589484.
      View in: PubMed
    141. Masoudi FA, Rumsfeld JS, Havranek EP, House JA, Peterson ED, Krumholz HM, Spertus JA. Age, functional capacity, and health-related quality of life in patients with heart failure. J Card Fail. 2004 Oct; 10(5):368-73. PMID: 15470645.
      View in: PubMed
    142. Masoudi FA, Rathore SS, Wang Y, Havranek EP, Curtis JP, Foody JM, Krumholz HM. National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction. Circulation. 2004 Aug 10; 110(6):724-31. PMID: 15289383.
      View in: PubMed
    143. Havranek EP, Simon TA, L'Italien G, Smitten A, Hauber AB, Chen R, Lapuerta P. The relationship between health perception and utility in heart failure patients in a clinical trial: results from an OVERTURE substudy. J Card Fail. 2004 Aug; 10(4):339-43. PMID: 15309702.
      View in: PubMed
    144. Havranek EP, Wolfe P, Masoudi FA, Rathore SS, Krumholz HM, Ordin DL. Provider and hospital characteristics associated with geographic variation in the evaluation and management of elderly patients with heart failure. Arch Intern Med. 2004 Jun 14; 164(11):1186-91. PMID: 15197043.
      View in: PubMed
    145. Havranek EP. Characteristics of a great review. J Am Coll Cardiol. 2004 May 19; 43(10):1927. PMID: 15145127.
      View in: PubMed
    146. Hockensmith ML, Estacio RO, Mehler P, Havranek EP, Ecder ST, Lundgren RA, Schrier RW. Albuminuria as a predictor of heart failure hospitalizations in patients with type 2 diabetes. J Card Fail. 2004 Apr; 10(2):126-31. PMID: 15101024.
      View in: PubMed
    147. Steinberg JS, Sadaniantz A, Kron J, Krahn A, Denny DM, Daubert J, Campbell WB, Havranek E, Murray K, Olshansky B, O'Neill G, Sami M, Schmidt S, Storm R, Zabalgoitia M, Miller J, Chandler M, Nasco EM, Greene HL. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation. 2004 Apr 27; 109(16):1973-80. PMID: 15051639.
      View in: PubMed
    148. Rumsfeld JS, Havranek E, Masoudi FA, Peterson ED, Jones P, Tooley JF, Krumholz HM, Spertus JA. Depressive symptoms are the strongest predictors of short-term declines in health status in patients with heart failure. J Am Coll Cardiol. 2003 Nov 19; 42(10):1811-7. PMID: 14642693.
      View in: PubMed
    149. Foody JM, Ferdinand FD, Galusha D, Rathore SS, Masoudi FA, Havranek EP, Nilasena D, Radford MJ, Krumholz HM. Patterns of secondary prevention in older patients undergoing coronary artery bypass grafting during hospitalization for acute myocardial infarction. Circulation. 2003 Sep 09; 108 Suppl 1:II24-8. PMID: 12970203.
      View in: PubMed
    150. Masoudi FA, Havranek EP, Wolfe P, Gross CP, Rathore SS, Steiner JF, Ordin DL, Krumholz HM. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J. 2003 Aug; 146(2):250-7. PMID: 12891192.
      View in: PubMed
    151. Masoudi FA, Wang Y, Inzucchi SE, Setaro JF, Havranek EP, Foody JM, Krumholz HM. Metformin and thiazolidinedione use in Medicare patients with heart failure. JAMA. 2003 Jul 02; 290(1):81-5. PMID: 12837715.
      View in: PubMed
    152. Havranek E. Pravastatin lowered coronary disease risk in elderly persons with or at risk for vascular disease. ACP J Club. 2003 Jul-Aug; 139(1):9. PMID: 12841713.
      View in: PubMed
    153. Rathore SS, Foody JM, Wang Y, Smith GL, Herrin J, Masoudi FA, Wolfe P, Havranek EP, Ordin DL, Krumholz HM. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA. 2003 May 21; 289(19):2517-24. PMID: 12759323.
      View in: PubMed
    154. Havranek EP, Masoudi FA, Rumsfeld JS, Steiner JF. A broader paradigm for understanding and treating heart failure. J Card Fail. 2003 Apr; 9(2):147-52. PMID: 12751136.
      View in: PubMed
    155. Masoudi FA, Havranek EP, Smith G, Fish RH, Steiner JF, Ordin DL, Krumholz HM. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol. 2003 Jan 15; 41(2):217-23. PMID: 12535812.
      View in: PubMed
    156. Havranek EP, Masoudi FA, Ralston DL, Susman NJ, Krumholz HM, Taylor JP. Future challenges in quality improvement in heart failure. Congest Heart Fail. 2002 Nov-Dec; 8(6):342-5. PMID: 12461325.
      View in: PubMed
    157. Gottlieb SS, Brater DC, Thomas I, Havranek E, Bourge R, Goldman S, Dyer F, Gomez M, Bennett D, Ticho B, Beckman E, Abraham WT. BG9719 (CVT-124), an A1 adenosine receptor antagonist, protects against the decline in renal function observed with diuretic therapy. Circulation. 2002 Mar 19; 105(11):1348-53. PMID: 11901047.
      View in: PubMed
    158. Krantz MJ, Woods JE, Havranek EP, Linas S. Simultaneous malignant hypertension and cardiac tamponade. Am J Kidney Dis. 2002 Mar; 39(3):E17. PMID: 11877597.
      View in: PubMed
    159. Havranek EP, Masoudi FA, Westfall KA, Wolfe P, Ordin DL, Krumholz HM. Spectrum of heart failure in older patients: results from the National Heart Failure project. Am Heart J. 2002 Mar; 143(3):412-7. PMID: 11868045.
      View in: PubMed
    160. Ramunno LD, French LL, O'Brien A, Ligor ML, Havranek EP, Taylor JP, Ordin DL. Improving heart failure care: CMS' initiative. Improving heart failure care in outpatient practices. Congest Heart Fail. 2002 Mar-Apr; 8(2):86-9. PMID: 11927782.
      View in: PubMed
    Havranek's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)